[Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
D000085:Acetates / Q000627:therapeutic use; D000873:Anthracenes / Q000627:therapeutic use*; D000891:Anti-Infective Agents, Local / Q000494:pharmacology / Q000627:therapeutic use*; D004341:Drug Evaluation; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D007783:Lactones / Q000627:therapeutic use*; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects / Q000201:enzymology; D013440:Sulfides / Q000627:therapeutic use
D000085:Acetates; D000873:Anthracenes; D000891:Anti-Infective Agents, Local; D007783:Lactones; D009824:Ointments; D013440:Sulfides; D005954:Glucosephosphate Dehydrogenase
Glucose-6-phosphat-Dehydrogenase und externe Antipsoriatica. Vergleich von Dithranol, Dithranolmono-, di- und -triacetat sowie 6-Hydroxy-2-oxobenzoxathiol